1 results match your criteria: "University of Massachusetts-Amherst (P.S.P.).[Affiliation]"
Circ Heart Fail
August 2016
From the Center for Quality of Care Research (T.L., P.S.P., M.-S.S., M.S., Q.R.P., G.V., M.T.S., P.K.L.), Division of Hospital Medicine, Department of Medicine (T.L., M.S., P.K.L.), and Division of Cardiology (Q.R.P., M.A.K., A.R.A., G.V., M.T.S.), Baystate Medical Center, Springfield, MA; Department of Medicine, Tufts University School of Medicine, Boston, MA (T.L., M.S., Q.R.P., M.A.K., A.R.A., G.V., M.T.S., P.K.L.); and School of Public Health and Health Sciences, University of Massachusetts-Amherst (P.S.P.).
Background: Heart failure (HF) inpatient mortality prediction models can help clinicians make treatment decisions and researchers conduct observational studies; however, published models have not been validated in external populations.
Methods And Results: We compared the performance of 7 models that predict inpatient mortality in patients hospitalized with acute decompensated heart failure: 4 HF-specific mortality prediction models developed from 3 clinical databases (ADHERE [Acute Decompensated Heart Failure National Registry], EFFECT study [Enhanced Feedback for Effective Cardiac Treatment], and GWTG-HF registry [Get With the Guidelines-Heart Failure]); 2 administrative HF mortality prediction models (Premier, Premier+); and a model that uses clinical data but is not specific for HF (Laboratory-Based Acute Physiology Score [LAPS2]). Using a multihospital, electronic health record-derived data set (HealthFacts [Cerner Corp], 2010-2012), we identified patients ≥18 years admitted with HF.